News
Evidence builds linking anticoagulation to COVID-19 survival
May 8, 2020
“Any family of mine who will have this disease absolutely will be on antithrombotic therapy and, actually, so are all of the patients at Mount Sinai.” – Valentin Fuster
News
New angiotensin studies in COVID-19 give more reassurance
May 6, 2020
A deluge of new data does not suggest harm with ACE inhibitors and angiotensin blockers in COVID-19 rates or outcomes.
Opinion
Moving beyond the hospital ward
May 6, 2020
As we move into a new era, our clarion call is to collaborate whenever and wherever we can.
News
Multisociety roadmap eyes restarting elective cardiac cases
May 6, 2020
A new consensus document provides guidance on the safe reintroduction of cardiovascular procedures and testing derailed by the COVID-19 pandemic.
News
Hydroxychloroquine-triggered QTc-interval prolongations mount in COVID-19 patients
May 4, 2020
Two single-center reports further documented the incidence of QTc-interval prolongations in COVID-19 patients treated with hydroxychloroquine.
News
Out-of-hospital cardiac arrests soar during COVID-19 in Italy
May 1, 2020
Four provinces in northern Italy report increases of various magnitudes, ranging from 18% to a stunning 187%.
News
Continuity rules
May 1, 2020
Hospital medicine outcomes are often hampered by suboptimal continuity of care.
News
COVID-19: A ‘marathon, not a sprint’ for psychiatry
May 1, 2020
Providing emotional support will help individuals engage with instrumental supports, said Dr. Joshua Morganstein.
News
New study of diabetes drug for COVID-19 raises eyebrows
May 1, 2020
Some question the safety of AstraZeneca’s just-launched DARE-19 study testing whether dapagliflozin will reduce adverse outcomes of COVID-19.
News
Survey: Hydroxychloroquine use fairly common in COVID-19
April 29, 2020
Testing and preparedness have increased, but a return to normal life could take another 6 months.